Literature DB >> 1440701

Secular trends in stroke incidence and mortality. The Framingham Study.

P A Wolf1, R B D'Agostino, M A O'Neal, P Sytkowski, C S Kase, A J Belanger, W B Kannel.   

Abstract

BACKGROUND: The reduction in US stroke mortality has been attributed to declining stroke incidence. However, evidence is accumulating of a trend in declining stroke severity.
METHODS: We examined secular trends in stroke incidence, prevalence, and fatality in Framingham Study subjects aged 55-64 years in three successive decades beginning in 1953, 1963, and 1973.
RESULTS: No significant decline in overall stroke and transient ischemic attack incidence or prevalence occurred. In women, but not men, incidence of completed ischemic stroke declined significantly. Stroke severity, however, decreased significantly over time. Stroke with severe neurological deficit decreased in later decades, with a fall in rates of severe stroke cases in which patients were unconscious on admission to the hospital. There was no substantial change in the case mix of infarcts and hemorrhages and no decline in hemorrhage to account for the decline in severity. The proportion of isolated transient ischemic attacks increased significantly over the 30 years studied, yielding an apparent and significant decline in case-fatality rates in men only.
CONCLUSIONS: Secular trends in stroke incidence and fatality did not follow a clear or definite pattern of decline. While a significant decline in stroke severity occurred over three decades, incidence of infarction fell only in women. The decline in total case fatality rates occurred only in men and resulted largely from an increased incidence of isolated transient ischemic attacks. The severity of completed stroke was significantly lower in the later decades under study.

Entities:  

Mesh:

Year:  1992        PMID: 1440701     DOI: 10.1161/01.str.23.11.1551

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  55 in total

1.  Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for prevention of stroke.

Authors:  S Warshafsky; D Packard; S J Marks; N Sachdeva; D M Terashita; G Kaufman; K Sang; A J Deluca; S J Peterson; W H Frishman
Journal:  J Gen Intern Med       Date:  1999-12       Impact factor: 5.128

2.  Can regional variation in "avoidable" mortality be explained by deaths outside hospital? A study from Sweden, 1987-90.

Authors:  R Westerling
Journal:  J Epidemiol Community Health       Date:  1996-06       Impact factor: 3.710

Review 3.  Losartan: a review of its use in stroke risk reduction in patients with hypertension and left ventricular hypertrophy.

Authors:  Marit D Moen; Antona J Wagstaff
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Epidemiology and risk factors of cerebral ischemia and ischemic heart diseases: similarities and differences.

Authors:  Ernest Palomeras Soler; Virgina Casado Ruiz
Journal:  Curr Cardiol Rev       Date:  2010-08

5.  Patient Selection for Drip and Ship Thrombolysis in Acute Ischemic Stroke.

Authors:  Michael J Lyerly; Karen C Albright; Amelia K Boehme; Reza Bavarsad Shahripour; John P Donnelly; James T Houston; Pawan V Rawal; Niren Kapoor; Muhammad Alvi; April Sisson; Anne W Alexandrov; Andrei V Alexandrov
Journal:  South Med J       Date:  2015-07       Impact factor: 0.954

6.  Aerobic exercise and weight loss reduce vascular markers of inflammation and improve insulin sensitivity in obese women.

Authors:  Alice S Ryan; Shealinna Ge; Jacob B Blumenthal; Monica C Serra; Steven J Prior; Andrew P Goldberg
Journal:  J Am Geriatr Soc       Date:  2014-03-17       Impact factor: 5.562

7.  Age at natural menopause and risk of ischemic stroke: the Framingham heart study.

Authors:  Lynda D Lisabeth; Alexa S Beiser; Devin L Brown; Joanne M Murabito; Margaret Kelly-Hayes; Philip A Wolf
Journal:  Stroke       Date:  2009-02-20       Impact factor: 7.914

Review 8.  Treatment of stroke in older patients. A state of the art review.

Authors:  G Harper
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

9.  Aspirin for primary prevention of cardiovascular events.

Authors:  F A Augustovski; S B Cantor; C T Thach; S J Spann
Journal:  J Gen Intern Med       Date:  1998-12       Impact factor: 5.128

Review 10.  The immune system in stroke: clinical challenges and their translation to experimental research.

Authors:  Craig J Smith; Catherine B Lawrence; Beatriz Rodriguez-Grande; Krisztina J Kovacs; Jesus M Pradillo; Adam Denes
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-15       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.